PlainRecalls
FDA Drug Moderate Class II Terminated

Ipratropium Bromide 0.5 mg and Albuterol Sulfate 3 mg Inhalation Solution, packaged in 30x3 mL Sterile Unit-Dose Vials, a) 30 count (NDC 0487-0201-03) and b) 60 count (NDC 0487-0201-60) vials per carton, Rx only, Nephron Pharmaceutical Corporation, Orlando, FL

Reported: October 21, 2015 Initiated: August 21, 2015 #D-0010-2016

Product Description

Ipratropium Bromide 0.5 mg and Albuterol Sulfate 3 mg Inhalation Solution, packaged in 30x3 mL Sterile Unit-Dose Vials, a) 30 count (NDC 0487-0201-03) and b) 60 count (NDC 0487-0201-60) vials per carton, Rx only, Nephron Pharmaceutical Corporation, Orlando, FL

Reason for Recall

Lack of Assurance of Sterility; potential exposure to non-sterile lubricant during the filling process

Details

Units Affected
a) 85,248 cartons and b) 35,292 cartons
Distribution
Nationwide
Location
Orlando, FL

Frequently Asked Questions

What product was recalled?
Ipratropium Bromide 0.5 mg and Albuterol Sulfate 3 mg Inhalation Solution, packaged in 30x3 mL Sterile Unit-Dose Vials, a) 30 count (NDC 0487-0201-03) and b) 60 count (NDC 0487-0201-60) vials per carton, Rx only, Nephron Pharmaceutical Corporation, Orlando, FL. Recalled by Nephron Pharmaceuticals Corp.. Units affected: a) 85,248 cartons and b) 35,292 cartons.
Why was this product recalled?
Lack of Assurance of Sterility; potential exposure to non-sterile lubricant during the filling process
Which agency issued this recall?
This recall was issued by the FDA Drug on October 21, 2015. Severity: Moderate. Recall number: D-0010-2016.